Nanox AI Ltd., a subsidiary of Nano-X Imaging Ltd. (NASDAQ: NNOX), has entered into a distribution agreement with Technologic s.r.l., an Italian company affiliated with Tecnologie Avanzate, to commercialize its AI-powered bone health solution, HealthOST, in Italy. The announcement was made by NEWMEDIAWIRE and details the company's latest move to expand its commercial presence in the Italian market. The agreement leverages Technologic's experience and local market knowledge to introduce HealthOST to Italian healthcare providers.
HealthOST is designed to analyze eligible routine CT scans to provide qualitative and quantitative assessments of the spine, helping clinicians identify patients who may benefit from further evaluation for musculoskeletal conditions such as osteoporosis. By integrating this AI-driven tool into routine imaging workflows, Nanox aims to support earlier detection of bone health issues and improve patient outcomes. The distribution agreement is a strategic step for Nanox (NASDAQ: NNOX) as it seeks to broaden the reach of its AI-based solutions beyond the United States and into key European markets.
The news matters because osteoporosis is a prevalent condition that often goes undiagnosed until a fracture occurs. HealthOST's ability to extract bone health insights from routine CT scans—without additional imaging sessions—could lead to more opportunistic screening and earlier interventions. For Italy, where the population is aging, such tools could help alleviate pressure on radiology departments by making better use of existing imaging data. For Nanox, the agreement represents a commercial validation of its AI portfolio and a potential revenue stream in a new geography.
Nanox describes itself as focused on driving the world's transition to preventive health care through an integrated, end-to-end medical imaging and healthcare services platform. The company combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. Its ecosystem includes Nanox.ARC, a cost-effective 3D multi-source digital tomosynthesis imaging system; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging; Nanox.CLOUD, a cloud-based platform for secure data management and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts; and Nanox Health IT, which delivers RIS, PACS, AI, dictation, and secure infrastructure solutions.
The distribution agreement with Technologic s.r.l. is intended to expand Nanox AI's commercial presence in Italy, but it also signals the company's broader ambition to make its AI tools a standard part of routine care. As healthcare systems increasingly look to extract more value from existing imaging data, solutions like HealthOST could become an important part of population health management. For readers and investors, the deal offers a concrete example of how Nanox is executing on its strategy to commercialize AI-driven diagnostics. The full press release can be viewed at https://ibn.fm/y9Zro, and the latest updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. Forward-looking statements in the announcement are subject to risks and uncertainties, including those described in the company's SEC filings.
